Journal
CLEVELAND CLINIC JOURNAL OF MEDICINE
Volume 77, Issue 12, Pages 859-+Publisher
CLEVELAND CLINIC
DOI: 10.3949/ccjm.77a.09103
Keywords
-
Categories
Funding
- Medtronic
Ask authors/readers for more resources
Monoamine oxidase (MAO) inhibitors were the first antidepressants introduced, but their use has dwindled because of their reported side effects, their food and drug interactions, and the introduction of other classes of agents. However, interest in MAO inhibitors is reviving. Here, we discuss their use, risks, and benefits in clinical medicine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available